Intrinsiqs

Is Mirum Pharmaceuticals, Inc. overvalued?

Mirum Pharmaceuticals, Inc. (MIRM) — key valuation metrics and fundamentals.

No verdict
Price
$93.99
Fair value
—
Current P/E
—
Normal P/E
—
Market cap
$6.14B
Dividend yield
0.0%
Return on equity
-734.0%
Sector
Healthcare

See the full interactive analysis →

Fair value compares MIRM's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 12 Nov 2026.